4-1002772-C-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The NM_000203.5:c.1230C>G variant in IDUA is a synonymous (silent) variant (p.Thr410=). The Grpmax Filtering AF (95% confidence) in gnomAD v4.1.0 is 0.2954 in the South Asian population, which is higher than the ClinGen Lysosomal Diseases VCEP’s threshold for BA1 (>0.005), and therefore meets this criterion (BA1). There is a ClinVar entry for this variant (Variation ID: 92628). In summary, this variant meets the criteria to be classified as benign for mucopolysaccharidosis type 1. IDUA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (Specifications Version 1.0.0): BA1.(Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on January 2, 2025) LINK:https://erepo.genome.network/evrepo/ui/classification/CA145870/MONDO:0001586/091

Frequency

Genomes: 𝑓 0.17 ( 2327 hom., cov: 32)
Exomes 𝑓: 0.16 ( 18473 hom. )

Consequence

IDUA
NM_000203.5 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel B:12

Conservation

PhyloP100: -1.80

Publications

15 publications found
Variant links:
Genes affected
IDUA (HGNC:5391): (alpha-L-iduronidase) This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008]
IDUA Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 1
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health
  • Scheie syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • Hurler syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
  • Hurler-Scheie syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IDUANM_000203.5 linkc.1230C>G p.Thr410Thr synonymous_variant Exon 9 of 14 ENST00000514224.2 NP_000194.2 P35475-1
IDUANM_001363576.1 linkc.834C>G p.Thr278Thr synonymous_variant Exon 8 of 13 NP_001350505.1
IDUAXM_047415650.1 linkc.1230C>G p.Thr410Thr synonymous_variant Exon 9 of 12 XP_047271606.1
IDUANR_110313.1 linkn.1318C>G non_coding_transcript_exon_variant Exon 9 of 14

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IDUAENST00000514224.2 linkc.1230C>G p.Thr410Thr synonymous_variant Exon 9 of 14 2 NM_000203.5 ENSP00000425081.2 P35475-1

Frequencies

GnomAD3 genomes
AF:
0.172
AC:
25972
AN:
151430
Hom.:
2331
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.211
Gnomad AMI
AF:
0.171
Gnomad AMR
AF:
0.123
Gnomad ASJ
AF:
0.166
Gnomad EAS
AF:
0.199
Gnomad SAS
AF:
0.302
Gnomad FIN
AF:
0.142
Gnomad MID
AF:
0.236
Gnomad NFE
AF:
0.152
Gnomad OTH
AF:
0.182
GnomAD2 exomes
AF:
0.174
AC:
14580
AN:
83954
AF XY:
0.190
show subpopulations
Gnomad AFR exome
AF:
0.208
Gnomad AMR exome
AF:
0.0740
Gnomad ASJ exome
AF:
0.161
Gnomad EAS exome
AF:
0.221
Gnomad FIN exome
AF:
0.156
Gnomad NFE exome
AF:
0.158
Gnomad OTH exome
AF:
0.174
GnomAD4 exome
AF:
0.161
AC:
212281
AN:
1321686
Hom.:
18473
Cov.:
36
AF XY:
0.165
AC XY:
107188
AN XY:
651162
show subpopulations
African (AFR)
AF:
0.220
AC:
5877
AN:
26738
American (AMR)
AF:
0.0863
AC:
2406
AN:
27868
Ashkenazi Jewish (ASJ)
AF:
0.160
AC:
3735
AN:
23360
East Asian (EAS)
AF:
0.160
AC:
4660
AN:
29150
South Asian (SAS)
AF:
0.298
AC:
21640
AN:
72516
European-Finnish (FIN)
AF:
0.158
AC:
5263
AN:
33272
Middle Eastern (MID)
AF:
0.220
AC:
861
AN:
3916
European-Non Finnish (NFE)
AF:
0.151
AC:
158602
AN:
1049976
Other (OTH)
AF:
0.168
AC:
9237
AN:
54890
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
9237
18475
27712
36950
46187
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5908
11816
17724
23632
29540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.171
AC:
25969
AN:
151538
Hom.:
2327
Cov.:
32
AF XY:
0.172
AC XY:
12705
AN XY:
74072
show subpopulations
African (AFR)
AF:
0.210
AC:
8697
AN:
41320
American (AMR)
AF:
0.123
AC:
1877
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.166
AC:
575
AN:
3472
East Asian (EAS)
AF:
0.199
AC:
1012
AN:
5096
South Asian (SAS)
AF:
0.301
AC:
1444
AN:
4792
European-Finnish (FIN)
AF:
0.142
AC:
1488
AN:
10512
Middle Eastern (MID)
AF:
0.229
AC:
67
AN:
292
European-Non Finnish (NFE)
AF:
0.152
AC:
10270
AN:
67758
Other (OTH)
AF:
0.181
AC:
383
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
1016
2031
3047
4062
5078
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0617
Hom.:
73
Bravo
AF:
0.169
Asia WGS
AF:
0.249
AC:
865
AN:
3452

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:4
Nov 02, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mucopolysaccharidosis type 1 Benign:4
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 02, 2025
ClinGen Lysosomal Storage Disorder Variant Curation Expert Panel
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The NM_000203.5:c.1230C>G variant in IDUA is a synonymous (silent) variant (p.Thr410=). The Grpmax Filtering AF (95% confidence) in gnomAD v4.1.0 is 0.2954 in the South Asian population, which is higher than the ClinGen Lysosomal Diseases VCEP’s threshold for BA1 (>0.005), and therefore meets this criterion (BA1). There is a ClinVar entry for this variant (Variation ID: 92628). In summary, this variant meets the criteria to be classified as benign for mucopolysaccharidosis type 1. IDUA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (Specifications Version 1.0.0): BA1. (Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on January 2, 2025) -

May 11, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
Dec 16, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 16438163, 28649516) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
1.6
DANN
Benign
0.50
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115790973; hg19: chr4-996560; API